T-C Wu
Overview
Explore the profile of T-C Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
217
Citations
5235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng S, Fan D, Tu H, Cheng M, Arend R, Levinson K, et al.
Cell Biosci
. 2024 Dec;
14(1):154.
PMID: 39722048
Background: We have previously developed a candidate therapeutic HPV DNA vaccine (pBI-11) encoding mycobacteria heat shock protein 70 linked to HPV16/18 E6/E7 proteins for the control of advanced HPV-associated oropharyngeal...
2.
Chi W, Hu Y, Huang H, Kuo H, Lin S, Kuo C, et al.
J Biomed Sci
. 2024 Oct;
31(1):94.
PMID: 39379923
Recent breakthroughs in cancer immunotherapies have emphasized the importance of harnessing the immune system for treating cancer. Vaccines, which have traditionally been used to promote protective immunity against pathogens, are...
3.
Lam B, Kung Y, Lin J, Tseng S, Tu H, Huang C, et al.
J Clin Invest
. 2023 Nov;
134(1).
PMID: 37917174
Even with the prolific clinical use of next-generation cancer therapeutics, many tumors remain unresponsive or become refractory to therapy, creating a medical need. In cancer, DCs are indispensable for T...
4.
Uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature
Xing D, Meyer C, Gross J, Argani P, Hung C, Wu T, et al.
Int J Gynecol Pathol
. 2023 Apr;
43(1):47-55.
PMID: 37043646
MEIS1::NCOA1/2 fusion sarcomas are a recently described novel entity arising in a variety of locations with a predilection for the genitourinary tract and gynecologic organs. Despite multiple locoregional recurrences, these...
5.
Chi W, Li Y, Huang H, Chan T, Chow S, Su J, et al.
J Biomed Sci
. 2022 Oct;
29(1):82.
PMID: 36243868
Coronavirus Disease 2019 (COVID-19) has been the most severe public health challenge in this century. Two years after its emergence, the rapid development and deployment of effective COVID-19 vaccines have...
6.
Peng S, Xing D, Ferrall L, Tsai Y, Hung C, Wu T
J Biomed Sci
. 2022 Oct;
29(1):80.
PMID: 36224625
Background: Human Papillomavirus type 18 (HPV18) is a high-risk HPV that is commonly associated with cervical cancer. HPV18 oncogenes E6 and E7 are associated with the malignant transformation of cells,...
7.
Liu Y, Shahi M, Miller K, Meyer C, Hung C, Wu T, et al.
Diagnostics (Basel)
. 2022 Jul;
12(7).
PMID: 35885469
Diagnosis of pelvic gastrointestinal stromal tumors (GISTs) can be challenging because of their nonspecific presentation and similarity to gynecological neoplasms. In this series, we describe the clinicopathological features of 20...
8.
Tseng S, Cheng M, Farmer E, Ferrall L, Kung Y, Lam B, et al.
J Immunother Cancer
. 2022 Apr;
10(4).
PMID: 35459734
Background: Type I interferons (IFN) promote dendritic cells maturation and subsequently enhance generation of antigen-specific CD8 +T cell for the control of tumor. Using type I interferons as an adjuvant...
9.
Nilforoushan N, Liu L, Finkelman B, Andersen J, Liu Y, James J, et al.
Int J Gynecol Pathol
. 2022 Mar;
42(2):182-191.
PMID: 35348533
Ovarian combined serous borderline tumor/low-grade serous carcinomas (SBT/LGSC) and mesonephric-like adenocarcinomas (MLA) have been previously reported and the presence of identical oncogenic somatic mutations in both components supports the concept...
10.
Peng S, Xing D, Ferrall L, Tsai Y, Roden R, Hung C, et al.
mBio
. 2022 Mar;
13(2):e0029622.
PMID: 35229636
No abstract available.